Nanogroup SA Cash Flow Conversion Efficiency

Latest as of June 2025: -0.141x

Nanogroup SA cash flow conversion efficiency. Based on the latest financial reports, Nanogroup SA (NNG) has a cash flow conversion efficiency ratio of -0.141x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-1.60 Million ≈ $-440.62K USD) by net assets (zł11.37 Million ≈ $3.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nanogroup SA (2015–2024)

Cash flow conversion efficiency of Nanogroup SA from 2015 to 2024. This chart illustrates how Nanogroup SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NNG stock price for real-time trading data and today's change.

Nanogroup SA Cash Flow Conversion Ratio Explained

Nanogroup SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nanogroup SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanogroup SA ranked by their cash flow conversion efficiency. Also see how much is Nanogroup SA worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Aseana Properties Limited
LSE:ASPL
0.070x
Selva Gida Sanayi AS
IS:SELVA
-0.049x
IVP Limited
NSE:IVP
0.067x
Sidma S.A. Steel Products
AT:SIDMA
0.036x
FAR Ltd
AU:FAR
-0.008x
Cannindah Resources Ltd
AU:CAE
-0.041x
Union Plastic Public Company Limited
BK:UP
-0.006x
Pelat Timah Nusantara Tbk
JK:NIKL
0.015x

Annual Cash Flow Conversion Efficiency for Nanogroup SA (2015–2024)

The table below shows the annual cash flow conversion efficiency of Nanogroup SA from 2015 to 2024. Review Nanogroup SA (NNG) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł15.93 Million
≈ $4.38 Million
zł-5.72 Million
≈ $-1.57 Million
-0.359x +61.11%
2023-12-31 zł5.16 Million
≈ $1.42 Million
zł-4.76 Million
≈ $-1.31 Million
-0.923x -94.91%
2022-12-31 zł7.78 Million
≈ $2.14 Million
zł-3.68 Million
≈ $-1.01 Million
-0.473x -23.81%
2021-12-31 zł8.37 Million
≈ $2.30 Million
zł-3.20 Million
≈ $-880.44K
-0.382x -432.65%
2020-12-31 zł18.77 Million
≈ $5.16 Million
zł-1.35 Million
≈ $-370.81K
-0.072x +39.41%
2019-12-31 zł13.31 Million
≈ $3.66 Million
zł-1.58 Million
≈ $-434.00K
-0.118x +47.04%
2018-12-31 zł15.52 Million
≈ $4.27 Million
zł-3.47 Million
≈ $-955.84K
-0.224x -22.01%
2017-12-31 zł14.17 Million
≈ $3.90 Million
zł-2.60 Million
≈ $-714.92K
-0.183x -202.75%
2016-12-31 zł12.75 Million
≈ $3.51 Million
zł-772.07K
≈ $-212.49K
-0.061x -153.46%
2015-12-31 zł5.28 Million
≈ $1.45 Million
zł-126.11K
≈ $-34.71K
-0.024x --

About Nanogroup SA

WAR:NNG Poland Biotechnology
Market Cap
$20.27 Million
zł73.66 Million PLN
Market Cap Rank
#24909 Global
#247 in Poland
Share Price
zł2.29
Change (1 day)
+0.66%
52-Week Range
zł2.28 - zł3.12
All Time High
zł13.00
About

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.